NasdaqCM - Delayed Quote • USD
INVO Bioscience, Inc. (INVO)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:57 PM EDT
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Steven M. Shum | CEO & Director | 260k | -- | 1971 |
Mr. Andrea Goren | Chief Financial Officer | 215k | -- | 1967 |
Mr. Michael Jos. Campbell | COO & VP of Business Development | 220k | -- | 1958 |
Mr. Bojan Mitrovic Ph.D. | Director of Sales US | -- | -- | -- |
Mr. Robert Joseph Bowdring Jr. | Treasurer & Secretary | -- | -- | 1958 |
Ms. Terah Krigsvold | Controller | -- | -- | -- |
INVO Bioscience, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 25
Description
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Corporate Governance
INVO Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Apr 19, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Apr 17, 202410-K/A: Periodic Financial ReportsSee Full Filing
- Apr 16, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Apr 11, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Apr 02, 20248-K/A: Corporate Changes & Voting MattersSee Full Filing
Upcoming Events
May 13, 2024 - May 17, 2024
INVO Bioscience, Inc. Earnings Call
Related Tickers
SINT Sintx Technologies, Inc.
0.0387
+8.10%
PACB Pacific Biosciences of California, Inc.
1.3600
-7.48%
NUWE Nuwellis, Inc.
0.2521
-14.95%
ABT Abbott Laboratories
106.89
-0.65%
DYNT Dynatronics Corporation
0.5898
+9.38%
BSGM BioSig Technologies, Inc.
1.3200
-10.81%
INSP Inspire Medical Systems, Inc.
234.19
+0.11%
NNOX Nano-X Imaging Ltd.
9.09
-2.36%
INBS Intelligent Bio Solutions Inc.
2.5700
-7.55%
CUTR Cutera, Inc.
1.9600
-8.84%